SCHEMBL168399

SCHEMBL168399

NC(=O)CN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5245144 0.97 KDM4E (0.60)
SCHEMBL1031783 0.97 KDM4E (0.60)
SCHEMBL63826 0.97 KDM4E (0.60)
Hydrochloric Acid SCHEMBL73679 0.97 KDM4E (0.60)
Hydrochloric Acid SCHEMBL2673610 0.95 KDM4E (0.58)
Hydrochloric Acid SCHEMBL7527100 0.95 KDM4E (0.58)
SCHEMBL1259867 0.94
SCHEMBL23014621 0.92 KDM4E (0.60)
SCHEMBL7748218 0.92 KDM4E (0.60)
SCHEMBL6174155 0.91 KDM4E (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4301736-B1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2025-10-08 EP claimed
EP-4619106-A2 TREATMENT OF ASCT2-DEPENDENT CANCERS Neupharma, Inc (US) 2025-09-24 EP claimed
CN-119798223-A (1H-indazol-5-yl) amino-2-pyridine derivative and application thereof 沈阳药科大学 2025-04-11 CN claimed
US-20240415819-A1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS QLi5 Therapeutics AG (DE) 2024-12-19 US claimed
WO-2024107753-A2 TREATMENT OF ASCT2-DEPENDENT CANCERS NEUPHARMA, INC (US) 2024-05-23 WO claimed
CN-112020356-B Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combinations 默克专利股份有限公司 2024-04-05 CN claimed
CN-115785070-B Pyrrolidinyl acetamide derivative, preparation method and application thereof 桂林医学院附属医院 2023-06-09 CN claimed
EP-4155296-A1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS Lead Discovery Center GmbH (DE) 2023-03-29 EP claimed
CN-115785070-A Pyrrolidinylacetamide derivative, preparation method and application thereof 桂林医学院附属医院 2023-03-14 CN claimed
US-11542265-B2 Pyrazolopyrimidine compounds and uses thereof INCYTE CORPORATION (US) 2023-01-03 US claimed
US-5461157-A Process for preparing pyrrolidinylacetamide derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US claimed
EP-0434943-B1 Polyene macrolide derivatives PRODOTTI ANTIBIOTICI SPA (IT) 1995-09-06 EP claimed
CN-1085893-A Process for preparing pyrrolidinylacetamide derivatives DAIICHI SEIYAKU CO (JP) 1994-04-27 CN claimed
US-5296597-A Antibiotics SPA SOCIETA' PRODOTTI ANTIBIOTICI S.P.A. (IT) 1994-03-22 US claimed
EP-0574952-A1 Process for preparing 2-oxopyrrolidinylacetamide derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1993-12-22 EP claimed
EP-0434943-A1 Polyene macrolide derivatives S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a. (IT) 1991-07-03 EP claimed
EP-0408782-A1 Antihypoxic agent NAUCHNOISSLEDOVATELSKI CHIMIKOPHARMATZEVTICHEN INSTITUT (BG) 1991-01-23 EP claimed
US-4939126-A 1-pyrrolidineacetamide derivatives and use thereof SANWA KAGAKU KENKYUSHO CO. LTD. (JP) 1990-07-03 US claimed
EP-0299495-A2 1-Pyrrolidineacetamide derivatives and use thereof SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1989-01-18 EP claimed
US-4122265-A APPETITE SUPPRESSANTS HOFFMANN-LA ROCHE INC. (US) 1978-10-24 US claimed